Crinetics Pharmaceuticals (CRNX) COO sells 9,911 shares for RSU taxes

Crinetics Pharmaceuticals’ Chief Operating Officer, Jeff E. Knight, sold 9,911 shares of common stock on March 16, 2026, to cover tax withholding obligations related to vested restricted stock units. The sales were executed at volume-weighted average prices of $37.11 and $37.77 per share under a Rule 10b5-1 trading plan. Following these transactions, Knight directly holds 112,018 shares of Crinetics common stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin